Drug
Copper
Copper is a pharmaceutical drug with 5 clinical trials. Historical success rate of 66.7%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_1
1
20%
Ph phase_2
4
80%
Phase Distribution
1
Early Stage
4
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
4(80.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(2)
Terminated(2)
Detailed Status
Completed2
Not yet recruiting1
Terminated1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
66.7%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (20.0%)
Phase 24 (80.0%)
Trials by Status
completed240%
not_yet_recruiting120%
terminated120%
withdrawn120%
Recent Activity
0 active trials
Showing 5 of 5
not_yet_recruitingphase_2
Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform
NCT01777919
withdrawnphase_2
Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.
NCT04265274
terminatedphase_1
A Phase Ib Study of Intravenous Copper Loading With Oral Disulfiram in Metastatic, Castration Resistant Prostate Cancer
NCT02963051
completedphase_2
Disulfiram in Recurrent Glioblastoma
NCT02678975
completedphase_2
Treatment With Copper in Patients With Mild Alzheimer´s Dementia
NCT00608946
Clinical Trials (5)
Showing 5 of 5 trials
NCT01777919Phase 2
Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform
NCT04265274Phase 2
Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.
NCT02963051Phase 1
A Phase Ib Study of Intravenous Copper Loading With Oral Disulfiram in Metastatic, Castration Resistant Prostate Cancer
NCT02678975Phase 2
Disulfiram in Recurrent Glioblastoma
NCT00608946Phase 2
Treatment With Copper in Patients With Mild Alzheimer´s Dementia
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5